This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
Antofagasta | JP Morgan downgrades to neutral from overweight |
Astrazeneca | Morgan Stanley downgrades to underweight from Equalweight |
Avocet Mining | Investec ups to Hold from sell; TP to 12.1p from 8.3p |
Bellway | Citigroup ups TP to 1650p from 1445p, Buy |
British Land | Jefferies cuts TP to 536p from 540p, Hold |
Bunzl | JP Morgan ups TP to 1520p from 1377p, overweight |
Centamin | Goldman Sachs cuts TP to 55p from 60p, Buy |
Centrica | HSBC ups taregt to 440p from 400p, overweight |
Drax Group | HSBC downgrades to neutral from overweight |
GlaxoSmithKline | Morgan Stanley downgrades to underweight from Equalweight |
Glencore Xstrata | JP Morgan cuts TP to 410p from 420p, overweight |
Hammerson | Jefferies ups TP to 507p from 505p, Hold |
Hellermanntyton Group | JP Morgan ups TP to 285p from 240p, overweight |
International Consolidated Airlines | RBC ups TP to 360p from 330p, outperform |
Interserve | JP Morgan ups TP to 592p from 558p, overweight |
Jupiter Fund Management | Citigroup ups TP to 400p from 355p, Buy |
Land Securities | Jefferies cuts TP to 902p from 908p, Hold |
Legal & General | Barclays ups TP to 205p from 188.4p, overweight |
Old Mutual | JP Morgan ups to overweight from neutral |
Petra Diamonds | Nomura ups TP to 185p from 170p, Buy |
SEGRO | Jefferies ups TP to 270p from 244p, Hold |
SIG | Panmure ups TP to 228p from 195p, Buy |
Synthomer | JP Morgan ups TP to 235p from 220p, neutral |
Thomas Cook | Jefferies ups TP to 200p from 155p, Buy |
Tui Travel | Jefferies ups TP to 380p from 315p, Hold |
Tui Travel | JP Morgan ups TP to 410p from 390p, neutral |
Source: Reuters News, AlphaTerminal, Dow Jones Newswires |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research